Results 1 to 10 of about 555,447 (206)

Studies on the Specificity of Narcotic Antagonists [PDF]

Anesthesiology, 1965
Francis F. Foldes, Maximilian Schapira, T. A. Torda, Deryck Duncalf, Hans P. Shiffman   +4 more
openalex   +2 more sources

Human pharmacology of narcotic antagonists. [PDF]

British Journal of Clinical Pharmacology, 1979
DR Jasinski
openalex   +2 more sources

Pain, Pathophysiological Mechanisms, and New Therapeutic Options for Alternative Analgesic Agents in Sheep: A Review and Investigation

Animals, 2021
Relief from suffering is the guiding principle of medical and veterinary ethics. Medical care for animals should be carried out to meet all welfare conditions.
Bogdan Feliks Kania, Danuta Wrońska, Urszula Bracha   +2 more
doaj   +1 more source

Impact of morphine dose on ticagrelor uptake and platelet inhibition in patients with ST-segment elevation myocardial infarction – A substudy from the prospective randomized MOVEMENT trial

Thrombosis Update, 2021
Background: Morphine delays ticagrelor effect in ST-segment elevation myocardial infarction (STEMI) patients, likely due to impaired gastrointestinal motility.
Manne Holm, Per Tornvall, Olof Beck, Thomas Fux, Jan van der Linden   +4 more
doaj   +1 more source

A Critical Review of the Neuropharmacological Effects of Kratom: An Insight from the Functional Array of Identified Natural Compounds

Molecules, 2023
Kratom (Mitragyna speciosa Korth. Havil) has been considered a narcotic drug for years, barred by the law in many parts of the world, while extensive research over the past few decades proves its several beneficial effects, some of which are still in ...
Rahni Hossain, Abida Sultana, Manit Nuinoon, Kunwadee Noonong, Jitbanjong Tangpong, Kazi Helal Hossain, Md Atiar Rahman   +6 more
doaj   +1 more source

Cannabinoid Hyperemesis Syndrome - A Case Report of an uncommon condition

European Psychiatry, 2023
Introduction The increasing prevalence of cannabis use in the world requires awareness of cannabis-related disorders such as cannabinoid hyperemesis syndrome (CHS).
B. Peixoto, M. Bicho, M. Cruz, M. Mendonça, V. Ustares   +4 more
doaj   +1 more source

The MOVEMENT Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background Morphine administration is a strong predictor of delayed onset of action of orally administered ticagrelor in patients with ST‐segment–elevation myocardial infarction, likely because of impaired gastrointestinal motility. The aim of this study
Manne Holm, Per Tornvall, Loghman Henareh, Ulf Jensen, Nanna Golster, Patrik Alström, Irene Santos‐Pardo, Nils Witt, Nikolai Fedchenko, Dimitrios Venetsanos, Olof Beck, Jan van der Linden   +11 more
doaj   +1 more source

Acute Myocardial Infarction following Naltrexone Consumption; a Case Report

Emergency, 2016
Cardiovascular effects of opioid withdrawal have long been studied. It was reported that patients with underlying ischemic heart disease and atherosclerotic vessels may be complicated by a sudden physical and emotional stress due to withdrawal syndrome ...
Bita Dadpour, Arash Gholoobi, Shahrad Tajoddini, Amir Habibi   +3 more
doaj   +1 more source

Medical expulsive therapy

Indian Journal of Urology, 2014
The objective of this review article is to present the current literature on medical expulsive therapy (MET) and help guide practitioners in the appropriate use of MET for treatment of stone disease.
Kyle D Wood, Ilya Gorbachinsky, Jorge Gutierrez   +2 more
doaj   +1 more source

Thyroid Function of Former Opioid Addicts on Naltrexone Treatment

Acta Medica, 2001
In order to assess thyroid function in former opioid addicts undergoing adjunctive naltrexone (NA) p.o. treatment, we studied 24 subjects (BMI±SD: 23.3±3.2 kg/m2) on 50 mg NA p.o. daily for 15 days to 14.5 months continuously.
Ioannis Ilias, Ioannis Kakoulas, Ioulia Christakopoulou, Kyriakos Katsadoros   +3 more
doaj   +1 more source